Respiratory syncytial virus (RSV) infection is a viral disease entity referenced in scholarly and public-health literature, including an entry in the Encyclopedia of Public Health [1]. The source material also identifies human respiratory syncytial virus as the orthopneumovirus that specifically affects infants and small children [2]. Beyond this general etiologic characterization, the provided snippets do not supply a fuller disease definition or laboratory classification [1][2].
Disease Profile
Respiratory syncytial virus infection (RSV)
呼吸道合胞病毒感染
Respiratory syncytial virus (RSV) infection is a viral respiratory infection identified in the source material as a public-health encyclopedia topic and as the human orthopneumovirus associated with respiratory illness [1][2]. The available evidence here is limited and largely bibliographic, so the profile should be read conservatively as a source-bound surveillance note rather than a full clinical monograph [1][3]. Source-backed detail on epidemiologic burden, transmission specifics, and prevention measures is not yet available in the provided snippets [1][3].
The available source text indicates that orthopneumoviruses can produce respiratory illness ranging from less severe upper-respiratory disease to severe bronchiolitis or pneumonia [2]. One source title links RSV infection with wheezing, which supports wheezing as a clinically relevant association in the literature, but the snippet does not provide a detailed symptom description [4]. Source-backed detail on incubation period, duration, complication frequency, or severity distribution is not yet available in the provided material [1][4][2].
The source material states that orthopneumoviruses are found among sheep, cows, and humans, and that human RSV is the orthopneumovirus specifically impacting infants and small children [2]. This establishes a host range across species and a recognized human pediatric focus, but it does not provide incidence, seasonality, outbreak history, geographic distribution, or burden estimates [2]. The remaining sources are scholarly metadata only and do not add epidemiologic detail beyond publication context [1][4][3][5].
The provided snippets do not state a transmission route, exposure mechanism, or environmental persistence for RSV infection [1][3][2]. Because the evidence boundary is limited to metadata and high-level taxonomy, route-specific statements would be speculative and are omitted here [1][2]. Source-backed detail on person-to-person spread, droplet transmission, contact exposure, or other mechanisms is not yet available [1][3].
The only explicitly supported risk group in the provided snippets is infants and small children, identified as the human population specifically impacted by RSV [2]. No additional risk strata, such as pregnancy, older age, chronic disease, prematurity, or immunocompromise, are stated in the supplied sources and therefore are not added here [2].
One source is explicitly concerned with preventing RSV infection, indicating that prevention is a recognized topic in the literature [3]. However, the snippet does not describe any specific measures, target populations, or intervention schedule, so no particular prevention strategy can be stated from the provided evidence [3]. Source-backed detail on immunization, prophylaxis, isolation, hygiene, or environmental control is not yet available [3].
For surveillance purposes, this record should be interpreted as a conservative RSV respiratory-infection concept anchored in source metadata and broad disease classification rather than a fully characterized case definition [1][2]. The strongest source-supported signals are its association with respiratory illness and with wheezing, plus its relevance to infants and small children [4][2]. Monitorers should note that the provided material does not include operational case criteria, confirmatory testing language, or epidemiologic thresholds [1][4][3].
- 1 Respiratory-Syncytial-Virus (RSV) Infection. Encyclopedia of Public Health. 2008. doi: 10.1007/978-1-4020-5614-7_3016. DOI: https://doi.org/10.1007/978-1-4020-5614-7_3016
- 2 Wikipedia contributors. Orthopneumovirus [Internet]. Wikipedia. cited 20 May 2026. Available from: https://en.wikipedia.org/wiki/Orthopneumovirus
- 3 PREVENTING RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION. Advances in Neonatal Care. 2005. doi: 10.1016/j.adnc.2004.10.006. DOI: https://doi.org/10.1016/j.adnc.2004.10.006
- 4 Respiratory syncytial virus (RSV) infection and wheezing. Wheezing Disorders in the Pre-School Child. 2003. doi: 10.3109/9780203624340-3. DOI: https://doi.org/10.3109/9780203624340-3
- 5 Respiratory Syncytial Virus (RSV). Encyclopedic Dictionary of Polymers. 2011. doi: 10.1007/978-1-4419-6247-8_14689. DOI: https://doi.org/10.1007/978-1-4419-6247-8_14689
- 6 Wikidata contributors. Respiratory Syncytial Virus Infection in Children [Internet]. Wikidata. cited 20 May 2026. Available from: https://www.wikidata.org/wiki/Q95417215
Figure 1 | Full historical trajectories across all reporting countries.
Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.
Dataset Archive
Supplementary Data | Multi-country disease dataset
Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.
Source Register
Official sources and update cadences used to construct the downloadable dataset.
Australia
Australian national notifiable diseases surveillance dashboard.
Official sourceJapan
Japan weekly infectious disease surveillance via NIID/JIHS.
Official source